However, this cohort combined all breast cancer subtypes, including HER2+ cancers and TNBC that represent the most aggressive breast cancer subtypes and showed the highest PVR mRNA levels (15), suggesting potential confounding variables. This evidence concerns the gene PVR and breast cancer.